CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel diagnostic tool for early detection of ovarian cancer using CRISPR technology. By leveraging electrochemical biosensing, it seeks to identify cancer biomarkers in urine, improving early diagnosis and patient outcomes.
Ovarian carcinoma (OC) is a leading cause of cancer deaths in postmenopausal women worldwide.
Unfortunately, it is diagnosed in the advanced stages (III/IV) with five-year survival rate of 20% and poor prognosis due to lack of distinct early symptoms.
The current diagnostic tools (pelvic examination and imaging techniques) often fail to detect premalignant tumors and standard biomarker (cancer antigen 125) analysis show low sensitivity and specificity.
The goal of this proposal is to develop a r…
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Serbia, Novi Sad
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
